Methods of determination of activation or inactivation of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9151766
APP PUB NO 20130157311A1
SERIAL NO

13633992

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An in vivo method of determining activation or inactivation of the atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems, the method comprising simultaneously detecting the presence or amount of atrial and brain natriuretic peptide prohormones (proANP and proBNP) or fragments thereof in a sample.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ORION DIAGNOSTICA OY02200 ESPOO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ala-Kopsala, Minna Oulu, FI 3 8
Haapalahti, Jouko Kempele, FI 3 8
Leppäluoto, Juhani Oulu, FI 7 44
Ruskoaho, Heikki Tyrnävä, FI 3 8
Vuolteenaho, Olli Oulu, FI 3 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 6, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00